250 related articles for article (PubMed ID: 7714409)
1. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.
Sharif NA; Su SX; Yanni JM
J Ocul Pharmacol; 1994; 10(4):653-64. PubMed ID: 7714409
[TBL] [Abstract][Full Text] [Related]
2. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
Sharif NA; Xu SX; Yanni JM
J Ocul Pharmacol Ther; 1996; 12(4):401-7. PubMed ID: 8951676
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
Sharif NA; Wiernas TK; Griffin BW; Davis TL
Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
Cardell LO; Edvinsson L
Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
[TBL] [Abstract][Full Text] [Related]
7. Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use.
Yanni JM; Stephens DJ; Parnell DW; Spellman JM
J Ocul Pharmacol; 1994; 10(4):665-75. PubMed ID: 7714410
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
9. Molecular properties of central and peripheral histamine H1 and H2 receptors.
Carman-Krzan M; Lipnik-Stangelj M
Pflugers Arch; 2000; 439(3 Suppl):R131-2. PubMed ID: 10653166
[TBL] [Abstract][Full Text] [Related]
10. Role of the histamine system in nefopam-induced antinociception in mice.
Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM
Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297
[TBL] [Abstract][Full Text] [Related]
11. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
[TBL] [Abstract][Full Text] [Related]
12. Histamine H(2) -like receptors in chick cerebral cortex: effects on cyclic AMP synthesis and characterization by [(3) H]tiotidine binding.
Zawilska JB; Woldan-Tambor A; Nowak JZ
J Neurochem; 2002 Jun; 81(5):935-46. PubMed ID: 12065605
[TBL] [Abstract][Full Text] [Related]
13. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
14. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
Drugs R D; 2005; 6(6):371-84. PubMed ID: 16274260
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs.
Yanni JM; Weimer LK; Sharif NA; Xu SX; Gamache DA; Spellman JM
Arch Ophthalmol; 1999 May; 117(5):643-7. PubMed ID: 10326962
[TBL] [Abstract][Full Text] [Related]
17. Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine.
Aslanian R; Mutahi Mw; Shih NY; Piwinski JJ; West R; Williams SM; She S; Wu RL; Hey JA
Bioorg Med Chem Lett; 2003 Jun; 13(12):1959-61. PubMed ID: 12781173
[TBL] [Abstract][Full Text] [Related]
18. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic antihistamines and H1-H4 receptors.
Wade L; Bielory L; Rudner S
Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):510-6. PubMed ID: 22918191
[TBL] [Abstract][Full Text] [Related]
20. Human conjunctival epithelial cells express histamine-1 receptors coupled to phosphoinositide turnover and intracellular calcium mobilization: role in ocular allergic and inflammatory diseases.
Sharif NA; Xu SX; Magnino PE; Pang IH
Exp Eye Res; 1996 Aug; 63(2):169-78. PubMed ID: 8983974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
